Oric Pharmaceuticals Share Price Today
(NASDAQ: ORIC)

Name: Oric Pharmaceuticals Share Price Today (NASDAQ: ORIC) - Oric Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Oric Pharmaceuticals share price is $7.95 & ₹691.40 as on 6 Mar 2025, 2.30 'hrs' IST

$7.95

▲

0.29

(3.79%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Oric Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Oric Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Oric Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Oric Pharmaceuticals share price movements

Today's Low: $7.66
Today's High: $8.00
$7.95
3.71%
Downside
Day's Volatility :4.27%
Upside
0.58%
52 Weeks Low: $6.33
52 Weeks High: $16.65
$7.95
20.38%
Downside
52 Weeks Volatility :61.98%
Upside
52.25%

Oric Pharmaceuticals (ORIC) Returns

Period	Oric Pharmaceuticals	Sector (Health Care)	Index (Russel 2000)
3 Months	-19.87%	2.1%	0.0%
6 Months	-19.2%	-4.1%	0.0%
1 Year	-52.21%	2.2%	0.0%
3 Years	12.15%	11.8%	-11.6%

Oric Pharmaceuticals (ORIC) Key Statistics

in dollars & INR

Previous Close	$7.66
Open	$7.69
Today's High	$7.9961
Today's Low	$7.655
Market Capitalization	$543.0M
Today's Volume	$209.1K
52 Week High	$16.65
52 Week Low	$6.33
Revenue TTM	$0.0
EBITDA	$-141.8M
Earnings Per Share (EPS)	$-1.83
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-54.73%

How to invest in Oric Pharmaceuticals Stock (ORIC) from India?

It is very easy for Indian residents to invest directly in Oric Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Oric Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Oric Pharmaceuticals or ORIC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Oric Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Oric Pharmaceuticals shares which would translate to 0.109 fractional shares of Oric Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Oric Pharmaceuticals, in just a few clicks!

Returns in Oric Pharmaceuticals (ORIC) for Indian investors in Rupees

The Oric Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Oric Pharmaceuticals investment value today

Current value as on today

₹54,557

Returns

₹45,443

(-45.44%)

Returns from Oric Pharmaceuticals Stock

₹50,405 (-50.41%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Oric Pharmaceuticals (ORIC)

17%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Oric Pharmaceuticals Stock from India on INDmoney has increased by 17% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Oric Pharmaceuticals

Nextech Invest AG
7.44%
BlackRock Inc
7.20%
Viking Global Investors LP
6.24%
VR Adviser, LLC
6.19%
Alkeon Capital Management, LLC
5.50%
Column Group LLC
4.99%

Analyst Recommendation on Oric Pharmaceuticals

Buy

93%Buy

6%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Oric Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Oric Pharmaceuticals Stock (ORIC)

What analysts predicted

Upside of 143.57%

Target:

$19.36

Current:

$7.95

Insights on Oric Pharmaceuticals Stock (Ticker Symbol: ORIC)

Price Movement
In the last 1 month, ORIC stock has moved down by -38.2%
ORIC vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 112.8%
ORIC vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 36.0%

Oric Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Oric Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Oric Pharmaceuticals (ORIC) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Oric Pharmaceuticals	-28.74%	-19.2%	-52.21%	12.15%	-70.28%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Oric Pharmaceuticals	NA	NA	NA	-1.96	-0.55	-0.34	NA	3.42
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Oric Pharmaceuticals	Buy	$543.0M	-70.28%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Oric Pharmaceuticals

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, that selectively target epidermal growth factor receptor (EGFR) exon 20 and human epidermal growth factor receptor 2 exon 20 with high potency towards exon 20 insertion mutations; and ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study. The company develops ORIC-533, an orally bioavailable small molecule inhibitor of CD73; and ORIC-613, a small molecule therapeutic intended to address a mechanism of innate resistance found in a subset of breast cancers. It has clinical development collaboration agreement for a potential Phase 2 study of ORIC-533 in multiple myeloma with Pfizer Inc.; a clinical trial collaboration and supply agreement with Bayer to evaluate ORIC-944 in combination with Nubeqa AR inhibitor; and a clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC 944 in combination with Erleada AR inhibitor. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Organization	Oric Pharmaceuticals
Employees	115
CEO	Dr. Jacob M. Chacko M.B.A., M.D.
Industry	Health Technology

Management People of Oric Pharmaceuticals

Name	Title
Dr. Richard A. Heyman Ph.D.	Co-Founder, Independent Chairman & Member of Scientific Advisory Board
Dr. Jacob M. Chacko M.B.A., M.D.	President, CEO & Director
Mr. Dominic G. Piscitelli CPA, M.B.A.	Chief Financial Officer
Dr. Pratik S. Multani M.D., M.S.	Chief Medical Officer
Dr. Charles L. Sawyers B.A., M.D., Ph.D.	Co-Founder & Member of Scientific Advisory Board
Dr. Scott W. Lowe Ph.D.	Co-Founder & Member of Scientific Advisory Board
Dr. Lori Sickels Friedman Ph.D.	Chief Scientific Officer
Dr. Christian V. Kuhlen Esq., J.D., M.D.	General Counsel
Mr. Daniel Iazzetti	VP & Head of People
Dr. Edna Chow Maneval Ph.D.	Executive Vice President of Clinical Development

Important FAQs about investing in ORIC Stock from India :

What is Oric Pharmaceuticals share price today?

Oric Pharmaceuticals share price today stands at $7.95, Open: $7.69 ; Previous Close: $7.66 ; High: $8.00 ; Low: $7.66 ; 52 Week High: $16.65 ; 52 Week Low: $6.33.

The stock opens at $7.69, after a previous close of $7.66. The stock reached a daily high of $8.00 and a low of $7.66, with a 52-week high of $16.65 and a 52-week low of $6.33.

Can Indians buy Oric Pharmaceuticals shares?

Yes, Indians can invest in the Oric Pharmaceuticals (ORIC) from India.

With INDmoney, you can buy Oric Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Oric Pharmaceuticals at zero transaction cost.

How can I buy Oric Pharmaceuticals shares from India?

It is very easy to buy Oric Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Oric Pharmaceuticals (ORIC) be purchased?

Yes, you can buy fractional shares of Oric Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Oric Pharmaceuticals stocks?

To start investing in Oric Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.